AQR Arbitrage’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-16,631
Closed -$263K – 468
2024
Q3
$263K Sell
16,631
-214,490
-93% -$3.38M 0.01% 326
2024
Q2
$3.53M Sell
231,121
-35,898
-13% -$544K 0.09% 191
2024
Q1
$4.38M Sell
267,019
-194,633
-42% -$3.07M 0.15% 150
2023
Q4
$6.76M Buy
461,652
+301,072
+187% +$4.2M 0.27% 102
2023
Q3
$2.31M Buy
160,580
+148,690
+1,251% +$2.32M 0.1% 213
2023
Q2
$195K Sell
11,890
-15,038
-56% -$245K 0.01% 475
2023
Q1
$450K Buy
+26,928
New +$434K 0.01% 506

Other funds holding BMEZ

AQR Arbitrage's BMEZ Position: Q4 2024 in Review

AQR Arbitrage sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2024, closing a stake of 16,631 shares — an estimated $263K sold.

AQR Arbitrage first reported a position in BMEZ in Q1 2023 and held it in 7 quarters. The position peaked at $6.76M in Q4 2023. 102 funds tracked by Wall St. Rank hold BMEZ as of Q4 2024.

  • AQR Arbitrage reported no remaining BlackRock Health Sciences Trust II position as of Q4 2024 after selling out during the quarter.
  • AQR Arbitrage sold 16,631 BlackRock Health Sciences Trust II shares in Q4 2024, an estimated $263K.
  • AQR Arbitrage first reported a position in BlackRock Health Sciences Trust II in Q1 2023 and held it in 7 quarters.
  • AQR Arbitrage's BlackRock Health Sciences Trust II position peaked at $6.76M in Q4 2023.
  • 102 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2024.

Based on AQR Arbitrage's 13F filing for Q4 2024, filed 14 Feb 2025.